26 Dec , 2024 By : Debdeep Gupta
Panacea Biotec Share Price, the share touched a 52-week high of Rs 489.00 and a 52-week low of Rs 112.70 on 12 December 2024 and 04 June 2024, respectively. Currently, the stock is trading 11.13 percent below its 52-week high and 285.58 percent above its 52-week low.
Panacea Biotec's share price locked at 5 percent upper circuit on December 26 following the company receiving a Letter Of Award (LoA) from the United Nations International Children's Emergency Fund (UNICEF) for the supply of 115 million doses of its bivalent oral polio vaccine (bOPV).
At 09:20 am, Panacea Biotec was quoting at Rs 456.25, up Rs 21.70, or 4.99 percent, on the BSE.
There were pending buy orders of 16,195 shares, with no sellers available.
The contract is worth ~ USD 14.95 million (~ Rs127 crore) and is to be executed calendar year 2025.
The LoA is for the supply of bOPV to UNICEF for its requirements in countries in Africa / Asia region as per the orders as may be received from time to time.
The company had reported a 158 percent jump in its Q2 net profit at Rs 4.80 crore.
The share price jumped 225 percent in the last six months.
The share touched a 52-week high of Rs 489.00 and a 52-week low of Rs 112.70 on 12 December 2024 and 04 June 2024, respectively.
Currently, the stock is trading 6.7 percent below its 52-week high and 304.84 percent above its 52-week low.
0 Comment